The present invention relates generally to a drug delivery device that facilitates high pressure medication injections. More particularly, the present invention relates to a drug delivery device that uses a mechanical advantage to facilitate high pressure medication injections. Still more particularly, the present invention relates to a drug delivery device including a system of levers and gears to translate an input force into an injection force to facilitate high pressure intradermal injections.
Insulin and other injectable medicaments are commonly given with syringes into the intradermal layer of the skin and other dense tissues. Intradermal medication injections result in faster uptake of the medication, thereby resulting in improved therapy. Such injections require higher injection pressures, upwards of 200 psi, than traditional subcutaneous injections.
Techniques and devices are known for administering an injection into the intradermal region of the skin. One method, commonly referred to as the Mantoux technique, uses a “standard” needles and syringe, i.e., a syringe typically used to administer intramuscular or subcutaneous injections. The health care provider administering the injection follows a specific procedure that requires a somewhat precise orientation of the syringe with regard to the patient's skin as the injection is administered. The health care provider must also attempt to precisely control the penetration depth of the needle into the patient's skin to ensure that it does not penetrate beyond the intradermal region. Such a technique is complicated, difficult to administer, and often may only be administered by an experienced health care professional.
As advances in understanding the delivery of drug proceeds, the use of intradermal delivery systems is expected to increase. However, use of a “standard” length needle to deliver a drug substance intradermally has its shortcomings, as noted above. Moreover, it is not possible to use a delivery device having a needle length suited for intradermal injection to aspirate a syringe with drug substance from a multi-use vial. Thus, there are shortcomings in the prior art that prevent administering an intradermal injection using a “standard” length needle and a multi-use vial. It would be advantageous to have a drug delivery device capable of accessing substances stored in multi-dose vials and delivering such substances into the intradermal region of the skin without encountering the shortcomings described above.
A conventional syringe 101 is shown in
Drug delivery pens, such as the exemplary drug delivery pen 100 shown in
The medicament cartridge 12 is typically a glass tube sealed at one end with the septum 16 and sealed at the other end with the stopper 15. The septum 16 is pierceable by a septum penetrating cannula 18 in the hub 20, but does not move with respect to the medicament cartridge 12. The stopper 15 is axially displaceable within the medicament cartridge 12 while maintaining a fluid tight seal.
The backpressure in subcutaneous injections is not very large, while the backpressure associated with intradermal injections may be many times greater than that of subcutaneous injections. Existing drug delivery pens require a large force to inject medication into the intradermal layer, thereby making the intradermal medication injection difficult. For example, the backpressure often exceeds 200 psi for an intradermal injection, while the backpressure for a subcutaneous injection is generally in the range of 30-50 psi. Thus, a need exists for a drug delivery pen that has a high mechanical advantage to facilitate an intradermal injection.
In accordance with an aspect of the present invention, a drug delivery device is provided that facilitates injecting insulin or other medicaments at high pressures.
In accordance with another aspect of the present invention, a drug delivery device has a system of levers and gears to produce sufficient force for an intradermal injection, without increasing the input force required from the user.
In accordance with another aspect of the present invention, a drug delivery device achieves mechanical advantage without requiring a secondary chamber, thereby reducing drug exposure outside of the original container.
In accordance with another aspect of the present invention, a drug delivery device is compact, thereby increasing usability and portability of the device.
Existing reusable and disposable insulin pens feature nut/screw drive mechanisms, are traditionally used for subcutaneous injections, and do not have a significant amount of mechanical advantage. To inject into an intradermal space, the user input force would be nearly 20 lbs, which is unacceptably high for insulin patients. Additionally, the components in the device can start to deform and fail at these high pressures. A drug delivery device according to an exemplary embodiment of the present invention transforms the user input into rotary motion that drives a system of gears, which have specified gear ratios, to create a mechanical advantage, thereby achieving the high pressure required for intradermal delivery. Additionally, the traditional cartridge components may be modified to withstand the injection pressure.
The lever and gear system creates the mechanical advantage that allows for a much more robust design of the individual components and critical interfaces when compared to a pen-type (screw/nut) device in which the user force and stroke of the injection motion are translated into a torque, which is then used to drive the drive screw 7 (
Objects, advantages, and salient features of the invention will become apparent from the following detailed description, which, taken in conjunction with the annexed drawings, discloses exemplary embodiments of the invention.
The above benefits and other advantages of the various embodiments of the present invention will be more apparent from the following detailed description of exemplary embodiments of the present invention and from the accompanying drawing figures, in which:
Throughout the drawings, like reference numbers will be understood to refer to like parts, components and structures.
In an exemplary embodiment of the present invention shown in
A user dials a dose on the dose setting wheel 221, inserts the needle 203 into the skin at the injection site, and then injects the medicament dose by pressing the dose delivery lever 231. The drug delivery device 201 uses a system of levers and gears to translate a user input force into an injection pressure that is sufficient for an intradermal injection. As shown in
The medicament dose is set by rotating the dose setting wheel 221, which is coupled via planetary gears 223, 225, 227 and 229 to a rising dose delivery lever 231. The dose setting wheel 221 is rotated downwardly (counter-clockwise as shown in
A lever assembly 231 includes a lever arm 233, which is in a first position as shown in
The movable rack 241 is engaged by the gear 232, such that rotation of the gear 232 moves the rack 241 through the cartridge 211 to deliver the medicament dose. An end of the rack 242 engages a stopper 213 disposed in the cartridge 213. Movement of the rack 242 pushes the stopper through the cartridge 211. The medicament dose corresponds to the distance traveled by the stopper 213 through the cartridge.
Gears 223, 227, 229 and 232 are rotatably disposed on a first shaft 208. The lever assembly and dose limiting member 251 are also rotatably disposed on the first shaft. The gear 225 is disposed on a second shaft 209.
When the medicament dose is set, the lever arm 233 is in the second position as shown in
A dose limiting component 251 engages the dose delivery lever 231 and the rack 241 to ensure correct positioning. The dose limiting component 251 has a dose limiting tab 253 that engages a groove 237 of the dose delivery lever 231. The groove 237 has a first end 238 and a second end 239. The dose limiting component 251 has a gear 255 that engages a second plurality of teeth 275 disposed on the rack 241. The dose limiting component 251 prevents dose setting when the drug volume is limited. When the available medicament remaining the cartridge 211 is less than a predetermined amount, the gear 255 engages the second plurality of teeth 275 of the rack 241, thereby rotating the dose limiting tab 253 to the first end 238 of the groove 237 when the lever arm 233 is in the first position. When an additional medicament dose is attempted to be set, the dose limiting tab 253 abuts the first end 238 of the groove 237 and prevents rotation of the lever arm 233. Accordingly, another medicament dose is prevented from being set.
The dose set mechanism features a planetary gear 225 to increase the distance between unit increments, thereby allowing the user to set the dose at (angle) increments similar to those of a current drug delivery pen 100 (
In a preferred embodiment, for a given user force, F1, a dose delivery lever arm, L1, a pinion radius and second lever arm, L2, the force multiplication is achieved using the following relationships: F1×L1=F2×L2.
Therefore, for this preferred embodiment, the force multiplier Mf, F1/F2 becomes the ratio of the areas, L2/L1=Mf=40/4.5=8.9.
Therefore, using gear ratios and lever advantages, an approximately eight to nine force multiplication (Mf) may be achieved.
A drug delivery device 301 in accordance with another exemplary embodiment of the present invention is shown in
The system of levers and gears are disposed in a housing 302 of the drug delivery device 301. A hub 303 is connected to the housing 302. A needle 371 is rigidly fixed in the housing 302. The needle 371 is in fluid communication with a medicament cartridge 351.
A dose set wheel 311 has a portion accessible through the housing 302 for setting the medicament dose. A dose set gear 313 is fixed to the dose set wheel 311. A dose set planet gear 315 is rotatably engaged with the dose set gear 313, which is fixed to a dose set internal gear 317. An outer surface of the internal gear 317 has a plurality of teeth for engaging with a flexible portion 332 of the lever assembly 331, as shown in
As shown in
The rack 361 has a first plurality of teeth 363 and a second plurality of teeth 365, as shown in
The foregoing embodiments and advantages are merely exemplary and are not to be construed as limiting the scope of the present invention. The description of exemplary embodiments of the present invention is intended to be illustrative, and not to limit the scope of the present invention. Various modifications, alternatives and variations will be apparent to those of ordinary skill in the art, and are intended to fall within the scope of the invention as defined in the appended claims and their equivalents.
This application is a continuation of U.S. Nonprovisional application Ser. No. 12/998,841, filed Sep. 20, 2011 and issued as U.S. Pat. No. 9,446,200 on Sep. 20, 2016, which is a U.S. national stage application under 35 U.S.C. § 371 of International Application No. PCT/US09/06419, filed Dec. 8, 2009, which claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application Ser. No. 61/193,592, filed Dec. 9, 2008, the entire content of all of said prior applications being hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
1718596 | Smith | Jun 1929 | A |
2669230 | Smoot | Feb 1954 | A |
2725877 | Reiter et al. | Dec 1955 | A |
3051172 | Bruchhaus | Aug 1962 | A |
3782380 | Van Der Gaast | Jan 1974 | A |
4447223 | Kaye et al. | May 1984 | A |
4576591 | Kaye | Mar 1986 | A |
4643723 | Smit | Feb 1987 | A |
4710178 | Henri | Dec 1987 | A |
4762515 | Grimm | Aug 1988 | A |
4820287 | Leonard | Apr 1989 | A |
4976686 | Ball | Dec 1990 | A |
5279585 | Balkwill | Jan 1994 | A |
5279586 | Balkwill | Jan 1994 | A |
5549575 | Giambattista | Aug 1996 | A |
5569214 | Chanoch | Oct 1996 | A |
5582598 | Chanoch | Dec 1996 | A |
5674204 | Chanoch | Oct 1997 | A |
5921966 | Bendek | Jul 1999 | A |
5944700 | Nguyen | Aug 1999 | A |
5957896 | Bendek | Sep 1999 | A |
5988452 | Dent | Nov 1999 | A |
6074372 | Hansen | Jun 2000 | A |
6096010 | Walters | Aug 2000 | A |
6159161 | Hodosh | Dec 2000 | A |
6221053 | Walters | Apr 2001 | B1 |
6248095 | Giambattista | Jun 2001 | B1 |
6277099 | Strowe | Aug 2001 | B1 |
6537242 | Palmer | Mar 2003 | B1 |
6595956 | Gross | Jul 2003 | B1 |
6599272 | Hjertman | Jul 2003 | B1 |
6932794 | Giambattista | Aug 2005 | B2 |
6936032 | Bush, Jr. | Aug 2005 | B1 |
6939319 | Anstead | Sep 2005 | B1 |
7018364 | Giambattista | Mar 2006 | B2 |
7169132 | Bendek | Jan 2007 | B2 |
20020007154 | Hansen et al. | Jan 2002 | A1 |
20040087904 | Langley | May 2004 | A1 |
20040097879 | Woolston | May 2004 | A1 |
20050090781 | Baba | Apr 2005 | A1 |
20050165363 | Judson | Jul 2005 | A1 |
20060069355 | Judson et al. | Mar 2006 | A1 |
20070167907 | Deslierres | Jul 2007 | A1 |
Number | Date | Country |
---|---|---|
62-502876 | Nov 1987 | JP |
H066505415 | Jun 1994 | JP |
2003126252 | May 2003 | JP |
2004508897 | Mar 2004 | JP |
2008538719 | Nov 2008 | JP |
0119434 | Mar 2001 | WO |
03080160 | Oct 2003 | WO |
2007113318 | Oct 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20160346474 A1 | Dec 2016 | US |
Number | Date | Country | |
---|---|---|---|
61193592 | Dec 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12998841 | US | |
Child | 15235388 | US |